Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Regorafenib Tablets

Approval Number

国药准字H20243059

Company江苏豪森药业集团有限公司

Registration Date

January 16, 2024

Drug Information

Generic Name

瑞戈非尼片

Dosage Form

片剂

Strength

40mg（按 C₂₁H₁₅ClF₄N₄O₃ 计）

Drug Type

化学药品

Registration Date

January 16, 2024

Company Information

Applicant Company

Company Name江苏豪森药业集团有限公司

Company Address

江苏省连云港经济技术开发区

Manufacturing Company

Company Name江苏豪森药业集团有限公司

Company Address

连云港经济技术开发区东晋路5号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

瑞戈非尼片 - NMPA 批准文号 | MedPath